An overview of responsive MRI contrast agents for molecular imaging.
about
A review of responsive MRI contrast agents: 2005-2014Overcoming the concentration-dependence of responsive probes for magnetic resonance imagingDetecting enzyme activities with exogenous MRI contrast agentsDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersEvaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging MethodsAdvances in Magnetic Resonance Imaging Contrast Agents for Biomarker DetectionImproved pH measurements with a single PARACEST MRI contrast agentA self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activityDetection of Sulfatase Enzyme Activity with a CatalyCEST MRI Contrast AgentMolecular Imaging Probe Development using Microfluidics.Molecular imaging without radiopharmaceuticals?Imaging of endogenous exchangeable proton signals in the human brain using frequency labeled exchange transfer imagingShape-changing magnetic assemblies as high-sensitivity NMR-readable nanoprobes.Maximizing T2-exchange in Dy(3+)DOTA-(amide)X chelates: fine-tuning the water molecule exchange rate for enhanced T2 contrast in MRI.Redox- and hypoxia-responsive MRI contrast agents.Dendrimeric β-cyclodextrin/Gd(III) chelate supramolecular host-guest adducts as high-relaxivity MRI probes.Imaging the intratumoral-peritumoral extracellular pH gradient of gliomas.Cellular and Molecular Imaging Using Chemical Exchange Saturation Transfer.A PARACEST agent responsive to inner- and outer-sphere phosphate ester interactions for MRI applications.Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.Bioresponsive, cell-penetrating, and multimeric MR contrast agents.PARACEST properties of a dinuclear neodymium(III) complex bound to DNA or carbonateA multislice gradient echo pulse sequence for CEST imagingAlternatives to gadolinium-based metal chelates for magnetic resonance imagingActivation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diestersEvaluations of extracellular pH within in vivo tumors using acidoCEST MRIActivation and retention: a magnetic resonance probe for the detection of acute thrombosis.A gadolinium(III) complex with 8-amidequinoline based ligand as copper(II) ion responsive contrast agent.Europium(III) DOTA-derivatives having ketone donor pendant arms display dramatically slower water exchange.Chemical exchange saturation transfer (CEST): what is in a name and what isn't?MRI probes for sensing biologically relevant metal ions.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerMagnetic resonance in the era of molecular imaging of cancerA catalyCEST MRI contrast agent that detects the enzyme-catalyzed creation of a covalent bondApplication of magnetic nanoparticles to gene delivery.Human in vitro suppression as screening tool for the recognition of an early state of immune imbalancePreparation, purification, and characterization of lanthanide complexes for use as contrast agents for magnetic resonance imaging.Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.Tumor-specific expression and detection of a CEST reporter gene.A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH.
P2860
Q27009286-E70D6518-4423-4E64-9C0F-D97CBC62C2B7Q27013727-102B03F7-88FE-4780-B37B-F2918AB68682Q27021691-DB55F8AC-01F4-442A-BB4E-CF909C6A142CQ28235682-80FDE607-5720-4A02-B221-32398F8EA4FAQ28821895-4875A685-9082-49F0-992D-49ED137B691FQ28830010-1107556F-D346-46EF-B9B4-ED1C788D8CAEQ28833257-84C2B4D5-1CFE-4E14-8A80-779C7ABC1DFFQ28833490-5E30A882-30B1-475E-8CE2-599D99709ED3Q28833645-FABD2F0C-4D75-4B65-9CEF-E102060DEA71Q30463697-948B8964-9FD2-4DDF-8354-CBF6338FF9E2Q30487686-4C563A3F-EC76-4EE2-97DC-6BF352AB2B12Q30588222-76D9ABE4-9F06-488D-9984-DD1B4DD18B1BQ30662281-73DD0C5D-0DA1-4E9B-A7BF-3C61E7C90607Q30726228-0FA12889-B828-45D0-B6B1-4EF42C5FBA75Q30820031-19FF87F4-0A55-4715-AD05-76D4C7727619Q30820441-F90B894C-DD40-4184-B25E-C5BBE74EEDECQ31036207-D7AE2A55-F478-401C-BCBB-D549DAAAC4D8Q31137184-6C68C054-F11B-4E2A-9571-8C116CB63AFDQ33421492-5961EF61-86A2-4A3B-B582-E879F0CF83C9Q33465177-4C0E2189-3CED-41DE-8EE3-8D2CE28535E5Q33470566-6A92AE99-067B-4C86-B92A-AD75D8A941D2Q33474469-8A29AB02-E175-4E5D-8839-5833F681121BQ33516069-AE125D84-7D29-45C5-9BA6-24509226DCABQ33557361-41EFB0E5-F549-438B-981A-86999CFDF8C8Q33590028-E8512AEA-DDDD-4CAA-8C72-48CF6C275FD9Q33663027-DB6899D4-578B-4C89-B883-DE2287B43E15Q33697883-9703AB0F-992D-46AF-BB2E-ECAC55AD81DDQ33757492-2BEFE1B9-D7FE-49F5-9861-E1479C16F7EFQ33816202-94C7EB08-7C5D-46DB-9CE1-D8AD96822528Q33825467-DE444488-2220-46FF-BA23-7ADFCB19B931Q33852470-C0278725-CA37-4EA8-86C4-F37E35F53672Q33881902-F9C094DD-37B7-4E97-BB98-DCFA930818B3Q33883070-E4DBF9F7-7066-4743-B3AD-05B4A2AE15B7Q34677812-4DC13B52-F9E1-4EB7-AAA7-475D18CFAB70Q35091789-3BBC7682-18B9-496A-8350-7F02BAC08956Q35379367-BFEA1802-14D1-4262-AF02-401451D32B68Q35940602-62C71920-81DE-4184-8E24-ED621F89FC62Q36003339-CDB2F3FC-E3B6-49E7-9914-91A4918C6FCAQ36182137-E406C98C-2928-4EC6-8DA8-1B0EFBE90FF2Q36404477-20BF87E9-FA5C-46E8-9CAD-ACC0EED5D9B0
P2860
An overview of responsive MRI contrast agents for molecular imaging.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
An overview of responsive MRI contrast agents for molecular imaging.
@ast
An overview of responsive MRI contrast agents for molecular imaging.
@en
type
label
An overview of responsive MRI contrast agents for molecular imaging.
@ast
An overview of responsive MRI contrast agents for molecular imaging.
@en
prefLabel
An overview of responsive MRI contrast agents for molecular imaging.
@ast
An overview of responsive MRI contrast agents for molecular imaging.
@en
P356
P1476
An overview of responsive MRI contrast agents for molecular imaging.
@en
P2093
Byunghee Yoo
Mark D Pagel
P304
P356
10.2741/2796
P577
2008-01-01T00:00:00Z